![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0891.png)
/
/
Question
Which answer is correct in prostate SBRT?
1. SBRT for prostate cancer is especially well
evaluated in high-risk disease.
2. Especially GI and not GU toxicity is an issue of
concern in SBRT for prostate cancer.
3. SBRT is using most frequently 5 fraction of doses
between 35 – 40Gy.